ATP-binding cassette transporter A1 mediates the beneficial effects of the liver X receptor agonist GW3965 on object recognition memory and amyloid burden in amyloid precursor protein/presenilin 1 mice.

ATP-binding cassette transporter A1 mediates the beneficial effects of the liver X receptor agonist GW3965 on object recognition memory and amyloid burden in amyloid precursor protein/presenilin 1 mice.

Item

http://www.wikidata.org/entity/Q30497102

Q30497102

about

Impact of apolipoprotein E on Alzheimer's disease ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models The liver X receptor agonist GW3965 improves recovery from mild repetitive traumatic brain injury in mice partly through apolipoprotein E ACAT1/SOAT1 as a therapeutic target for Alzheimer's disease Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy Defensive effect of lansoprazole in dementia of AD type in mice exposed to streptozotocin and cholesterol enriched diet Identification of a Chrysanthemic Ester as an Apolipoprotein E Inducer in Astrocytes Allopregnanolone promotes regeneration and reduces β-amyloid burden in a preclinical model of Alzheimer's disease Role of Abca7 in mouse behaviours relevant to neurodegenerative diseases.Genomic convergence and network analysis approach to identify candidate genes in Alzheimer's disease.Retinoic acid isomers facilitate apolipoprotein E production and lipidation in astrocytes through the retinoid X receptor/retinoic acid receptor pathway.Frontiers in therapeutic development of allopregnanolone for Alzheimer's disease and other neurological disorders.In vivo and in vitro effects of an apolipoprotein e mimetic peptide on amyloid-β pathology Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with Alzheimer-like Tau pathology.Dab2 attenuates brain injury in APP/PS1 mice via targeting transforming growth factor-beta/SMAD signaling.Nuclear receptors in neurodegenerative diseases.HDL and cognition in neurodegenerative disorders.Cholesterol in brain disease: sometimes determinant and frequently implicated.Effects of NR1H3 genetic variation on the expression of liver X receptor α and the progression of Alzheimer's disease Up-regulation of the ATP-binding cassette transporter A1 inhibits hepatitis C virus infection.Improvement of memory deficits and amyloid-β clearance in aged APP23 mice treated with a combination of anti-amyloid-β antibody and LXR agonist Nuclear receptors as therapeutic targets for Alzheimer's disease Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice Genomics of Dementia: APOE- and CYP2D6-Related Pharmacogenetics.Role of Liver X Receptor in AD Pathophysiology.Neuroregenerative mechanisms of allopregnanolone in Alzheimer's disease.Bexarotene-Activated Retinoid X Receptors Regulate Neuronal Differentiation and Dendritic Complexity.ABC Transporters and the Alzheimer's Disease Enigma.Combined Liver X Receptor/Peroxisome Proliferator-activated Receptor γ Agonist Treatment Reduces Amyloid β Levels and Improves Behavior in Amyloid Precursor Protein/Presenilin 1 Mice Apolipoprotein E level and cholesterol are associated with reduced synaptic amyloid beta in Alzheimer's disease and apoE TR mouse cortex Reducing human apolipoprotein E levels attenuates age-dependent Aβ accumulation in mutant human amyloid precursor protein transgenic mice.Mechanisms underlying the rapid peroxisome proliferator-activated receptor-γ-mediated amyloid clearance and reversal of cognitive deficits in a murine model of Alzheimer's disease.Liver X receptor agonist treatment significantly affects phenotype and transcriptome of APOE3 and APOE4 Abca1 haplo-deficient mice Role of liver X receptors in cholesterol efflux and inflammatory signaling (review)Association studies of several cholesterol-related genes (ABCA1, CETP and LIPC) with serum lipids and risk of Alzheimer's disease.Abca1 deficiency affects Alzheimer's disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice.Regulation of cerebral cholesterol metabolism in Alzheimer disease.Response to comments on "ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models"Hormonal modulators of glial ABCA1 and apoE levels SUMO and Alzheimer's disease.

P2860

Q24567759-8715DDA4-F206-414F-A05C-912C232A1DF6 Q24628845-B31A5C68-605B-472F-963E-FA3A3D08645E Q27321301-4D316C91-982F-47D1-937D-F5567D2D35B5 Q28081654-ACEBA6A5-4FF8-44D7-834E-F146F0F7B136 Q28282855-C52D9F12-D110-416A-B1D2-C76E1DE4C9C0 Q28535014-E613FF69-482E-4573-9DD8-CC1FAC0CD8DB Q28553918-31933CA9-DCF6-4752-AA55-4CC0E71DE8B6 Q28740634-42691C8B-DFBA-4EFD-A9DA-B6820F21EA2F Q30463254-D272DA51-44DA-4026-A0AC-76593AFB922A Q33637672-71AE3323-EEF3-443F-9FA3-C7738C4B350D Q33676328-2FFE3D90-8650-4BA3-9FD6-5206D6075941 Q33972726-C86CC0CD-1D6D-4A7C-8860-75FD07AAE142 Q33995580-131DB830-7206-497E-B7B0-219EF9E9A780 Q34044871-E6C132FB-9360-4A16-81EF-069CD0B1647F Q34096401-AE9EDB8F-CFC5-4C91-86C4-A2F4AAF0D0D0 Q34580020-DF013F30-7172-4B65-86A1-24253BB31FE4 Q34614842-B517FCB7-0195-4B31-8CB9-5E1BC7FDED8A Q34621446-93E52836-D973-49A5-A6EF-7200973A8A9D Q35053654-B7741361-EF22-4749-9686-4F0894F4D38D Q35125004-D91C3F64-FA3F-4346-85F5-6B7E2F12ABD8 Q35137114-4C440C28-9C99-4CE7-B16F-6E397E3F3934 Q35165186-A98A1CA3-7C53-47D0-B583-0FF465AD5B11 Q35166985-D674F317-FD9A-41E7-B146-CEBC9AB24E34 Q35852564-D48BD85F-CE8A-47D6-9312-1FBB53746544 Q35882575-3684FF7C-F60A-4299-9053-D6D38B84BBFF Q35972117-604536D9-85BD-4E03-BD42-4C427E0BA691 Q35995939-AF863524-F62A-43B8-A0F2-0A55D8420DD8 Q36005085-54E37478-A449-443A-9F4C-E80C6499D02C Q36065117-83AE7B76-0C68-4F3C-961D-99406A971ABE Q36115080-58F73D88-5634-4E34-9C0E-D974E5FB3A29 Q36206696-BBCC74DC-2E0B-402B-BEAA-D6D41DEB030E Q36208400-88A2D21F-270E-49EB-864F-112930B90AEE Q36291665-C6085318-2CF5-4FB4-B40C-E58A164DE386 Q36383228-B2BC76C6-E246-447F-8B0C-5189777EBA58 Q36493774-4D41767D-D6D6-40AE-B629-A1A6C40197BB Q36822983-81C83F13-3522-4403-BF75-FCED297B4320 Q36841850-3BB47C3F-4B0A-43BF-87FE-694B8CF97FBE Q37022972-3A8AE5A9-F08C-48EB-A560-DE56C3F36049 Q37222706-C4778722-6D21-4421-9CD5-08FA348320F1 Q37297379-A5CA5C5D-67F1-43A4-9F51-8207475AE837

P2860

ATP-binding cassette transporter A1 mediates the beneficial effects of the liver X receptor agonist GW3965 on object recognition memory and amyloid burden in amyloid precursor protein/presenilin 1 mice.

Item

http://www.wikidata.org/entity/Q30497102

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu